Antigen binding molecules having modified Fc regions and altered binding to Fc receptors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070111281A1
SERIAL NO

11430283

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to antigen binding molecules, including antibodies, comprising a Fc region having one or more amino acid modifications, wherein the antigen binding molecule exhibits altered binding to one or more Fc receptors as a result of the modification(s). The invention is further directed to polynucleotides and vectors encoding such antigen binding molecules, to host cells comprising the same, to methods for making the antigen binding molecules of the invention, and to their use in the treatment of various diseases and disorders, e.g., cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROCHE GLYCART AGSCHLIEREN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brunker, Peter Hittnau, CH 4 355
Ferrara, Koller Claudia Zurich, CH 49 665
Sondermann, Peter Rudolfstetten-Friedlisberg, CH 26 158
Stuart, Fiona Zurich, CH 1 90
Umana, Pablo Zurich, CH 247 5409

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation